SAN DIEGO, September 1, 2023 – ProSciento, Inc., the leading clinical research organization (CRO) for metabolic diseases, will present scientific data related to its Patient Access & Engagement (PAE) platform at the NASH Paris Meeting taking place September 7-8, 2023.
The scientific poster titled “Participant Feasibility: Direct Engagement with Patients to Impact MASH Trial Design and Site Selection” evaluates data from ProSciento’s Patient Access & Engagement (PAE) platform, presented at this year’s NASH Paris Meeting. The poster evaluates the data from pre-study participant feasibility campaigns for 12 metabolic dysfunction-associated steatohepatitis (MASH) study protocols utilizing a database of 29,879 individuals with comorbidities related to the prevalence of MASH/MASLD. The resulting insights held significant value in demonstrating study feasibility, identifying participation barriers, aiding in site selection decisions, enhancing patient enrollment and retention, and ultimately improving overall efficiency.
View the poster on ProSciento’s website at https://prosciento.com/publication-library/posters-registration/?id=116258.
About ProSciento, Inc.
ProSciento is the leading provider of clinical research and patient engagement solutions for metabolic continuum diseases with unparalleled expertise in diabetes, obesity, and steatotic liver disease. As a full-service clinical research organization (CRO), ProSciento works with clients across the globe to design and conduct multinational clinical trials, from early clinical development planning through phase III. With two decades as a leading scientific contributor to metabolic continuum research, ProSciento has built trusted relationships with clients, partners, and patients, supporting the development of therapeutics and devices that make an important difference in the lives of individuals with metabolic diseases. For more information, please visit www.prosciento.com.
For business development inquiries, please contact:
Vice President, Global Business Development, ProSciento, Inc.
For media inquiries, please contact:
Senior Director, Corporate Communications, ProSciento, Inc.